OTTAWA, June 30, 2017 /CNW/ - Health Canada is advising health care professionals and Canadians that the Canadian authorizedversion of NARCAN will transition onto the market by July 5, 2017.
NARCAN is a nasal spray form of naloxone, the life-saving drug that temporarily reverses the effects of an opioid overdose.
On July 5, 2017, the Interim Order will expire. Product obtained under the Interim Order can continue to be used, but new orders will be for the Canadian authorized NARCAN product. There will be a period of time where both products will be available as transition occurs.
NARCAN is the same product in Canada and the U.S. Minor labelling differences are the only distinctions between the Canadian and American versions of the product.
For both versions of the product, it is important to monitor and respect the expiry dates.
Information for anyone who may need to administer naloxone
For more information on how to obtain the Canadian NARCAN Nasal Spray, contact the manufacturer at:
Report health or safety concerns
To report a side effect to a health product to Health Canada:
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
Également disponible en français
SOURCE Health Canada
Subscribe to our Free Newsletters!
Cholestatic jaundice occurs when the flow of bile (chole) between the liver and small intestine is ...
Opportunistic infections are microbial infections that can cause disease in persons with a weak ...
The state health insurance programs provide health care support to the below poverty line (BPL) ...View All